Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
... who are at risk of death due to end-stage left
ventricular failure. The DuraHeart LVAS carries a CE Mark ... who are at risk of death due to end-stage left
ventricular failure. We are excited to offer this ... to artificial mechanical assist devices. Left
ventricular Assist Systems are a type of mechanical ...
Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's Treatments
... disease. The method, based on measuring
ventricular size, provides a new approach to monitor brain ... Informatics.
"Based on ADNI data, measuring
ventricular change may be one of the most robust outcomes for ... Perceptive has developed a novel method of
ventricular measurement that accurately reflects brain ...
HeartWare International Clinical Trial Shows 90% Survival at 180 Days
... clinical trial of the HeartWare(R) Left
ventricular Assist System. The results were presented by Dr. ... miniaturized implantable heart pumps, or Left
ventricular Assist Devices (LVADs), to treat patients suffering from advanced heart failure. The HeartWare(R)
ventricular Assist System features the HVAD(TM) pump, the ...
Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
... April 7 /PRNewswire/ -- The DuraHeart(TM) Left
ventricular Assist System (LVAS) shows sustained benefits in ... active magnetically levitated centrifugal left
ventricular assist system, are published on line in the ... 68 patients who received the DuraHeart Left
ventricular Assist System between January 2004 and July 2008 ...
Pfizer Contributes Critical Data to URMC Drug Safety Initiative
... of its adverse effect of the process of cardiac
ventricular repolarization - the split-second period between ... of an ECG recording that measures the process of
ventricular repolarization. Prolongation of the QT interval associated with episodes of fatal
ventricular arrhythmias is a leading cause of removal of ...
Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
... Heart Inc. today announced
its EXCOR(R) Pediatric
ventricular assist device (VAD) has received
unconditional ... and distributes implantable and external
ventricular assist
devices for patients of every age and body ... company also manufactures the implantable left
ventricular assist
device INCOR(R), which has been designed ...
American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant
... physical rehabilitation efforts.
The
ventricular assist devices allow for physical rehabilitation ... However, the
miniaturized Berlin Heart EXCOR(R)
ventricular assist device recently
became available in North ... development and
refinement of mechanical
ventricular assist devices in the pediatric
population, ...
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
... significantly reduces mean 24 hour
ventricular rate, on top of
other rate control agents. The ... over six months.
"Effective control of
ventricular rate in patients with permanent AF is
associated ... available therapeutic
option is to control the
ventricular response rate to prevent deterioration
of ...
Discharge of First U.S. DuraHeart(TM) Patient
... patient implanted with the
DuraHeart(TM) Left
ventricular Assist System (LVAS). The patient was
discharged ... years. He is the first U.S.
patient to receive a
ventricular assist system that utilizes advanced
magnetic ... for Terumo Heart, Inc.
Earlier generation Left
ventricular Assist devices are prone to
hemolysis, blood ...
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
... the first U.S. implant of the DuraHeart(TM) Left
ventricular Assist
System (LVAS) took place on July 30 at the ... is the world's first third
generation left
ventricular assist system combining a centrifugal pump with
a ... who are at risk of death due to end-stage left
ventricular heart
failure. Yoshifumi Naka, M.D., Ph.D., from ...
HUYA Bioscience Int'l Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
... channel blocker for the treatment of
atrial or
ventricular arrhythmias. In April 2008, HUYA announced ... 15 percent of strokes occur
in people with AF(1).
ventricular Arrhythmia (VA), a severely abnormal
heart ... may have a useful role
in the treatment of
ventricular arrhythmias.
In the United States, HBI-3000 is ...
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
... (greater than or equal to 20
percent) in left
ventricular ejection fraction (LVEF) that was below the
lower ... of Grade
1 or 2. Two Grade 2 asymptomatic left
ventricular ejection fraction
decreases, one Grade 3 ... been
associated with reports of decreases in left
ventricular ejection fraction
(LVEF). Caution should be taken ...
Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
... coronary artery occlusion would preserve left
ventricular function.
The primary endpoints in COR-0002 were left
ventricular diastolic
relaxation indices as assessed by left
ventricular pressure-volume loops
and ST segment changes as ...
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
... These
include:
-- An implantable mixed-flow
ventricular assist device designed specifically for patients up to two years of age -- Another mixed-flow
ventricular assist device that can be implanted ... assist systems -- Apically implanted axial-flow
ventricular assist device -- ...
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
... VELCADE plus DOXIL arm experienced left
ventricular ejection fraction decrease (defined as ... heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including ... with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports ...
Myocor Receives Approval for Percutaneous Trial
... granted conditional approval of
the Valvular and
ventricular Improvement Via iCoapsys Delivery ... functional mitral
regurgitation (FMR) and left
ventricular (LV) dysfunction.
About the company:
Myocor ... heart geometry and
function. By addressing both
ventricular and valvular issues, Myocor's
therapies offer a ...
New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
... blood
pressure and insulin levels, increased left
ventricular mass and left
atrial size, and other ... risk of heart disease due to increased left
ventricular mass. "There is a very clear picture here -- and ... obtained echocardiograms to determine
left
ventricular mass and left atrial size and laboratory tests ...
Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
... results for the company's
DuraHeart(TM) Left
ventricular Assist System (LVAS) will be presented by
Dr. Aly ... are at risk of death due to end-stage left
ventricular failure. It is
the only approved implantable Left
ventricular Assist System combining a
centrifugal pump with ...
New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients
... result in comparable improvements in radial strain, strain rate and left
ventricular ejection fraction in elderly patients with severe symptomatic aortic ... can use echocardiograms, or heart ultrasound, to view the heart's left
ventricular end systolic volume (this measurement refers to the volume of blood in the ...
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
... patients receiving Gleevec.
Severe congestive heart failure and left
ventricular dysfunction have occasionally been reported. Most of the patients with ... patients with HES and cardiac involvement, cases of cardiogenic shock/left
ventricular dysfunction have been associated with the initiation of imatinib therapy. ...
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
... the United States, studying the new, third generation DuraHeart(TM) Left
ventricular Assist System (LVAS). Dr. Feldman joins Dr. Francis Pagani, Director of ... these patients is access to artificial mechanical assist devices. Left
ventricular Assist Systems (LVAS) are a type of mechanical circulatory device ...
Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
... awaiting heart transplant who are at risk of death due to end-state left
ventricular failure.
The medical team led by Yoshifumi Naka, M.D., Ph.D., ... these patients is access to artificial mechanical assist devices. Left
ventricular Assist Systems (LVAS) are a type of mechanical circulatory device ...
Implantable Defibrillators Lower Risk of Death in Older Heart Patients
... heart muscle that results in diminished pumping action --- called left
ventricular systolic dysfunction --- are candidates for ICDs to prevent death from ... study recruited 986 consecutive patients who had diminished left
ventricular function --- meaning the pumping chamber of the heart was functioning at ...
Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
... exacerbation of congestive heart failure, and new onset of decreased left
ventricular ejection fraction has been reported, including reports in patients with no risk factors for decreased left
ventricular ejection fraction. There have been reports of acute diffuse infiltrative ...
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
... deaths reported in the safety population and the expanded access program.
ventricular repolarization abnormalities may have contributed to their occurrence.
... common in the elderly.
Severe congestive heart failure and left
ventricular dysfunction have occasionally been reported. Most of the patients with ...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
... common in the elderly.
Severe congestive heart failure and left
ventricular dysfunction have occasionally been reported. Most of the patients with ... deaths reported in the safety population and the expanded access program.
ventricular repolarization abnormalities may have contributed to their occurrence.
...
Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
... cerebrovascular event, left atrium size greater than 50
mm or left
ventricular ejection fraction lower than 40 percent). Patients
with decompensated ... fibrillation: the Efficacy and safety of
dRonedArone for the control of
ventricular rate during atrial fibrillation
(ERATO) study. Am Heart J. 2008 ...
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
... patients receiving
Gleevec.
Severe congestive heart failure and left
ventricular dysfunction have
occasionally been reported. Most of the patients with ... patients with HES and cardiac involvement, cases of cardiogenic
shock/left
ventricular dysfunction have been associated with the initiation
of Gleevec therapy. ...
Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
... at the University
of Michigan to move forward with the DuraHeart(TM) Left
ventricular Assist
System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant ... support for patients who are at risk of death
due to end-stage left
ventricular failure. It is currently the only CE
marked implantable LVAS combining a ...
Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
... of congestive heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including reports in patients with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports of acute diffuse ...
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
... of congestive heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including reports in patients with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports of acute diffuse ...
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
... of congestive heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including reports in patients with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports of acute diffuse ...
Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics
... (KBR) enables accurate three
dimensional reconstruction of right
ventricular volume and function in
patients with tetralogy of fallot (TOF) in ... Based Reconstruction, our VentriPoint Diagnostic
System completes critical
ventricular measurements in significantly less
time and lower cost than traditional ...
Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
... after market launch) who were implanted with the DuraHeart(TM)
(LVAS) Left
ventricular Assist System between January 2004 and March 2008.
The average duration of ... support for patients who are at risk of death
due to end-stage left
ventricular failure. It is currently the only CE
marked implantable LVAS combining a ...
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
... studies, including data showing statistically significant
reductions in
ventricular arrhythmias with ranolazine. The labeling also
notes that the ability of ... overload is expected
to improve myocardial relaxation and decrease left
ventricular diastolic
stiffness. The doses of the product in the EU will be 375 mg, ...
Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
... to hemodynamic
overload.
Entitled "Three-Dimensional Analysis of Right
ventricular Remodeling in
Repaired Tetralogy of Fallot," the paper was authored by Dr. ... diagnostic tool that can
provide measurement of a heart's volume and
ventricular ejection fraction.
The VentriPoint Diagnostic System, together with its ...
Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
... congestion in patients admitted with
worsening heart failure and left
ventricular dysfunction. These findings
were presented at the 57th American College of ... pressure (p<0.03 for all doses) was observed, with a reduction of the
left
ventricular diastolic volume (p=0.02 for the highest dose) and an
increase in cardiac ...
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
... of congestive heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including reports in patients with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports of acute diffuse ...
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
... in mind -- Reverse Mode Switch(TM): designed to eliminate unnecessary
ventricular pacing -- Quick Convert(TM): provides the ability for patients to receive pacing therapy for
ventricular tachycardias "Our CRM team is refocused on delivering therapy systems ...
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
... of congestive heart
failure, and/or new onset of decreased left
ventricular ejection fraction
has been reported, including reports in patients with few or no risk
factors for decreased left
ventricular ejection fraction. There have been
rare reports of acute diffuse ...